Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks

Physiological Genomics

Volumn 17, Issue , 2004, Pages 283-291

  Hall, Jennifer L ^a   Grindle, Suzanne ^b   Han, Xinqiang ^a   Fermin, David ^a   Park, Soon ^b   Chen, Yingjie ^a   Bache, Robert J ^a   Mariash, Ami ^a   Guan, Zhanjun ^a   Ormaza, Sofia ^b   Thompson, Jeanne ^c   Graziano, Judith ^a   De Sam Lazaro, Shireen E ^a   Pan, Shuchong ^d   Simari, Robert D ^d   Miller, Leslie W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Fairview Medical Group   (United States)

^d MAYO CLINIC   (United States)

Author keywords

GATA 4; Microarray; SDF 1; Stretch; Unloading

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BINDING PROTEIN; CELL PROTEIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENDOMUCIN; FIBROBLAST GROWTH FACTOR 9; FLUOXETINE; GENE PRODUCT; HEPARIN; MILRINONE; NESIRITIDE; NEUROPILIN 1; NITRATE; PROTEIN SPROUTY 1; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 4 BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASODILATOR AGENT; VASOPRESSIN; ALPHA CHEMOKINE; DNA BINDING PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; SPRY1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE ASSIST DEVICE; HUMAN; HUMAN TISSUE; MALE; MECHANICAL STRESS; MECHANOTRANSDUCTION; MORTALITY; MUSCLE HYPERTROPHY; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATOR GENE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS; UNINDEXED SEQUENCE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS;

ADULT; AGED; CHEMOKINES, CXC; DNA-BINDING PROTEINS; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENOMICS; HEART-ASSIST DEVICES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NEUROPILIN-1; PHOSPHOPROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 3042802300     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00004.2004     Document Type: Article

References (52)

1. Altemose GT, Gritsus V, Jeevanandam V, Goldman B, and Margulies KB. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 16: 765-773, 1997.
2. Baba HA, Stypmann J, Grabellus F, Kirchhof P, Sokoll A, Schafers M, Takeda A, Wilhelm MJ, Scheld HH, Takeda N, Breithardt G, and Levkau B. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res 59: 390-399, 2003.
3. Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, Koerner MM, El Banayosy A, Koerfer R, Holtz J, and Zerkowski HR. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100: 11216-11223, 1999.
4. Birks EJ, Latif N, Owen V, Bowles C, Felkin LE, Mullen AJ, Khaghani A, Barton PJ, Polak JM, Pepper JR, Banner NR, and Yacoub MH. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation 104: 1233-1240, 2001.
5. Blaxall BC, Tschannen-Moran BM, Milano CA, and Koch WJ. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41: 1096-1106, 2003.
6. Boheler KR, Volkova M, Morrell C, Garg R, Zhu Y, Margulies K, Seymour AM, and Lakatta EG. Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure. Proc Natl Acad Sci USA 100: 2754-2759, 2003.
7. Brown MD and Hudlicka O. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6: 1-14, 2003.
8. Bruckner BA, Stetson SJ, Perez-Verdia A, Youker KA, Radovancevic B, Connelly JH, Koerner MM, Entman ME, Frazier OH, Noon GP, and Torre-Amione G. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20: 457-464, 2001.
9. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS, and Quertermous T. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108: 1432-1439, 2003.
10. Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, and Bache RJ. Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14: 251-260, 2003. First published June 24, 2003; 10.1152/ physiolgenomics.00022.2003.
11. Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F III, DeMets DL, and White BG. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339: 1810-1816, 1998.
12. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, and Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303-310, 1991.
13. Colucci WS, Wright RF, and Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments: 2. N Engl J Med 314: 349-358, 1986.
14. de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, Saavedra JM, Boomsma F, van Gilst WH, and van Veldhuisen DJ. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc Res 57: 434-442, 2003.
15. Depre C, Davies PJ, and Taegtmeyer H. Transcriptional adaptation of the heart to mechanical unloading. Am J Cardiol 83: 58H-63H, 1999.
16. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, and Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4: 1269-1275, 1998.
17. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, and Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97: 2316-2322, 1998.
18. Flesch M, Margulies KB, Mochmann HC, Engel D, Sivasubramanian N, and Mann DL. Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 104: 2273-2276, 2001.
19. Hasegawa K, Lee SJ, Jobe SM, Markham BE, and Kitsis RN. cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96: 3943-3953, 1997.
20. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, and Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102: 2713-2719, 2000.
21. Herzig TC, Jobe SM, Aoki H, Molkentin JD, Cowley AW Jr, Izumo S, and Markham BE. Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci USA 94: 7543-7548, 1997.
22. Huang X, Pan W, Park S, Han X, Miller LW, and Hall J. Modeling the relationship between LVAD support time and gene expression changes in the human heart by penalized partial least squares. Bioinformatics Jan. 29, 2004.
23. Hudlicka O. Mechanical factors involved in the growth of the heart and its blood vessels. Cell Mol Biol Res 40: 143-152, 1994.
24. Huebert R, Ezzat K, Li Q, Fermin D, Park S, Miller LW, and Hall JL. Identification of Sprouty 1, an intrinsic inhibitor or the ERK cascade, in the heart (Abstract). Circulation 108: 1224, 2003.
25. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, and Bravo E. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure, Circulation 92: II191-II195, 1995.
26. Levy D, Larson MG, Vasan RS, Kannel WB, and Ho KK. The progression from hypertension to congestive heart failure. JAMA 275: 1557-1562, 1996.
27. Li J, Hampton T, Morgan JP, and Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest 100: 18-24, 1997.
28. Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, and Feldman AM. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 104: 1147-1152, 2001.
29. Madigan JD, Barbone A, Choudhri AF, Morales DL, Cai B, Oz MC, and Burkhoff D. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121: 902-908, 2001.
30. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100: 999-1008, 1999.
31. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 8: S500-S505, 2002.
32. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, and Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 59: 609-613, 1995.
33. McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, and Hobbs RE. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg 109: 409-417, 1995.
34. McCarthy PM and Smith WA. Mechanical circulatory support: a long and winding road. Science 295: 998-999, 2002.
35. Milkiewicz M, Brown MD, Egginton S, and Hudlicka O. Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 8: 229-241, 2001.
36. Molkentin JD, Kalvakolanu DV, and Markham BE. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alphamyosin heavy-chain gene. Mol Cell Biol 14: 4947-4957. 1994.
37. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248-254, 1992.
38. Packer M. Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice. Prog Cardiovasc Dis 41: 39-52, 1998.
39. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325: 1468-1475, 1991.
40. Razeghi P, Young ME, Ying J, Depre C, Uray IP, Kolesar J, Shipley GL, Moravec CS, Davies PJ, Frazier OH, and Taegtmeyer H. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 97: 203-209, 2002.
41. Rivello HG, Meckert PC, Vigliano C, Favaloro R, and Laguens RP. Cardiac myocyte nuclear size and ploidy status decrease after mechanical support. Cardiovasc Pathol 10: 53-57. 2001.
42. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, and Haas TL. Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283: H1430-H1438, 2002. First published June 13, 2002; 10.1152/ajpheart.00082.2002.
43. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, and Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
44. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, and Block AJ. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 356: 615-620, 2000.
45. Sedding DG, Seay U, Fink L, Heil M, Kummer W, Tillmanns H, and Braun-Dullaeus RC. Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 108: 616-622, 2003.
46. Small EM and Krieg PA. Transgenic analysis of the atrial natriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. Dev Biol 261: 116-131, 2003.
47. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262, 1999.
48. 2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res 45: 883-888, 2000.
49. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
50. Uray IP, Connelly JH, Frazier O, Taegtmeyer H, and Davies PJ. Altered expression of tyrosine kinase receptors Her2/neu and GP130 following left ventricular assist device (LVAD) placement in patients with heart failure. J Heart Lung Transplant 20: 210, 2001.
51. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, and Hall JL. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90: 340-347, 2002.
52. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.